SouthState Corp’s Medpace MEDP Stock Holding History

SouthState Corp’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2	Closed	-$610	–	1732
2025 Q1	$610	Buy	+2	New	+$673	﹤0.01%	1442
2024 Q2	–	Sell	-299	Closed	-$121K	–	720
2024 Q1	$121K	Buy	+299	New	+$105K	0.01%	283

Other funds holding MEDP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return

SouthState Corp's MEDP Position: Q2 2025 in Review

SouthState Corp sold out of Medpace (MEDP) in Q2 2025, closing a stake of 2 shares — an estimated $610 sold.

SouthState Corp first reported a position in MEDP in Q1 2024 and held it in 2 quarters. The position peaked at $121K in Q1 2024. 602 funds tracked by Wall St. Rank hold MEDP as of Q2 2025.

SouthState Corp reported no remaining Medpace position as of Q2 2025 after selling out during the quarter.
SouthState Corp sold 2 Medpace shares in Q2 2025, an estimated $610.
SouthState Corp first reported a position in Medpace in Q1 2024 and held it in 2 quarters.
SouthState Corp's Medpace position peaked at $121K in Q1 2024.
602 funds tracked by Wall St. Rank held Medpace as of Q2 2025.

Based on SouthState Corp's 13F filing for Q2 2025, filed 6 Aug 2025.